Cargando…

Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates

After the outbreak of COVID-19, billions of vaccines with different types have been administrated, including recombinant protein vaccines and mRNA vaccines. Although both types of SARS-CoV-2 vaccine can protect people from viral infection, their differences in humoral and cellular immune responses a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yixin, Zhang, Huicong, Meng, Liuxian, Li, Fusheng, Yu, Changyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161160/ https://www.ncbi.nlm.nih.gov/pubmed/35663946 http://dx.doi.org/10.3389/fimmu.2022.906457

Ejemplares similares

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans
por: Forgacs, David, et al.
Publicado: (2021)

mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection
por: Casado, José L., et al.
Publicado: (2023)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose
por: Nag, Kakon, et al.
Publicado: (2021)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults
por: van den Berg, Robert A., et al.
Publicado: (2018)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders
por: Kasai, Ryousuke, et al.
Publicado: (2023)

A novel mRNA vaccine, SYS6006, against SARS-CoV-2
por: Xu, Ke, et al.
Publicado: (2023)

Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
por: Qin, Jane, et al.
Publicado: (2023)

Impact of SARS-CoV-2 mRNA vaccine on arthritis condition in rheumatoid arthritis
por: Takatani, Ayuko, et al.
Publicado: (2023)

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
por: Oyaert, Matthijs, et al.
Publicado: (2022)

Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
por: Pascale, Sara Pasquina, et al.
Publicado: (2022)

Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders
por: Iwayama, Hideyuki, et al.
Publicado: (2022)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2020)

SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
por: Bartsch, Yannic C, et al.
Publicado: (2022)

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
por: Wang, Yang, et al.
Publicado: (2021)

Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response
por: Nakagama, Sachie, et al.
Publicado: (2023)

A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques.
por: Baisa, Gary, et al.
Publicado: (2021)

“A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.”
por: Baisa, Gary, et al.
Publicado: (2020)

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
por: López-Cortés, Luis F., et al.
Publicado: (2023)

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Zitt, Emanuel, et al.
Publicado: (2021)

Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination
por: Al Jurdi, Ayman, et al.
Publicado: (2022)

Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination
por: Taus, Ellie, et al.
Publicado: (2023)

Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
por: Rysava, Romana, et al.
Publicado: (2022)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia
por: Merid, Yared, et al.
Publicado: (2023)

mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
por: Girard, Bethany, et al.
Publicado: (2022)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
por: Marchitto, Lorie, et al.
Publicado: (2023)

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
por: Rudi, Erika, et al.
Publicado: (2022)

Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
por: Keshavarz, Behnam, et al.
Publicado: (2022)

A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022)

Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination
por: Hernández-Luis, Pablo, et al.
Publicado: (2022)

Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine
por: Bai, Jie, et al.
Publicado: (2022)

Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
por: Baron, Frédéric, et al.
Publicado: (2022)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gkh41dv719oo093rqo21rgmtkc